Viridian (VRDN) Q2 Net Loss Widens 55%
Viridian Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $16.96
+10% in 1d after detection
Post-detection moves
1h
—
1d
+10%
3d
+8.0%
7d
+10%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS